16-56334785-A-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_020988.3(GNAO1):c.521A>G(p.Asp174Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D174N) has been classified as Likely pathogenic.
Frequency
Consequence
NM_020988.3 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 17Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- movement disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- neurodevelopmental disorder with involuntary movementsInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020988.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | NM_020988.3 | MANE Select | c.521A>G | p.Asp174Gly | missense | Exon 5 of 9 | NP_066268.1 | ||
| GNAO1 | NM_138736.3 | c.521A>G | p.Asp174Gly | missense | Exon 5 of 8 | NP_620073.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | ENST00000262493.12 | TSL:1 MANE Select | c.521A>G | p.Asp174Gly | missense | Exon 5 of 9 | ENSP00000262493.6 | ||
| GNAO1 | ENST00000262494.13 | TSL:1 | c.521A>G | p.Asp174Gly | missense | Exon 5 of 8 | ENSP00000262494.7 | ||
| GNAO1 | ENST00000638705.1 | TSL:1 | c.521A>G | p.Asp174Gly | missense | Exon 5 of 8 | ENSP00000491223.1 |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 35
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with involuntary movements Pathogenic:1Other:1
Variant classified as Pathogenic and reported on 07-05-2018 by The University of Oklahoma Health Sciences Center. GenomeConnect-GNAO1 assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect: significant decrease in protein expression levels and functional ability (PMID: 28747448); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23993195, 31175295, 27072799, 28503590, 34622282, 29895856, 28202424, 34685729, 27625011, 35964317, 30838255, 36939041, 36198807, 28747448)
Developmental and epileptic encephalopathy, 17 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at